Skip to main content
. 2015 Apr 9;106(6):734–739. doi: 10.1111/cas.12658

Table 3.

Efficacy of combination therapy according to RECIST

Response Level 1 (= 2) Level 2a (= 3) Level 2b (= 3) Level 3 (= 4) Total (= 12)
CR 1 0 0 0 1
PR 0 2 0 3 5
SD 0 1 2 1 4
PD 1 0 0 0 1
NE 0 0 1 0 1
Response rate (CR+PR) 50.0% 66.7% 0.0% 75.0% 50.0% (95% CI, 21.1–78.9)
Disease control rate (CR+PR+SD for ≥16 weeks) 50.0% 100.0% 66.7% 100.0% 83.3% (95% CI, 51.6–97.9)

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NE, not evaluable